- Home
- NA vs OCEA Comparison
NA vs OCEA Comparison
Compare NA & OCEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NA
- OCEA
- Stock Information
- Founded
- NA 2019
- OCEA 2019
- Country
- NA China
- OCEA United States
- Employees
- NA N/A
- OCEA N/A
- Industry
- NA Semiconductors
- OCEA Biotechnology: Pharmaceutical Preparations
- Sector
- NA Technology
- OCEA Health Care
- Exchange
- NA Nasdaq
- OCEA Nasdaq
- Market Cap
- NA 32.3M
- OCEA 30.4M
- IPO Year
- NA 2022
- OCEA N/A
- Fundamental
- Price
- NA $4.42
- OCEA $0.72
- Analyst Decision
- NA
- OCEA
- Analyst Count
- NA 0
- OCEA 0
- Target Price
- NA N/A
- OCEA N/A
- AVG Volume (30 Days)
- NA 162.9K
- OCEA 48.2K
- Earning Date
- NA 09-18-2024
- OCEA 11-26-2024
- Dividend Yield
- NA N/A
- OCEA N/A
- EPS Growth
- NA N/A
- OCEA N/A
- EPS
- NA N/A
- OCEA N/A
- Revenue
- NA $6,991,446.00
- OCEA N/A
- Revenue This Year
- NA N/A
- OCEA N/A
- Revenue Next Year
- NA N/A
- OCEA N/A
- P/E Ratio
- NA N/A
- OCEA N/A
- Revenue Growth
- NA N/A
- OCEA N/A
- 52 Week Low
- NA $2.75
- OCEA $0.52
- 52 Week High
- NA $47.50
- OCEA $7.79
- Technical
- Relative Strength Index (RSI)
- NA 45.38
- OCEA 29.58
- Support Level
- NA $2.77
- OCEA $0.83
- Resistance Level
- NA $9.68
- OCEA $1.00
- Average True Range (ATR)
- NA 1.36
- OCEA 0.06
- MACD
- NA -0.02
- OCEA -0.02
- Stochastic Oscillator
- NA 23.88
- OCEA 24.93
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.